alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

May 7, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-6464

OK International, Inc:

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/Notice_of_Product_Exclusions

_05.09.19.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

May 7, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-5300

United Scope LLC: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/Notice_of_Product_Exclusions

_05.09.19.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
INPUT

.05

80
Consistent with USTR's Section 301 notice, OMRON Management Center of America, Inc. requests

confidential treatment for the information designated as business confidential in this submission. Such

information consists of information that would not customarily be released to the public, including

business or trade secrets regarding production costs and processes, data on sales, product characteristics

customers, destinations, and other product, sales, and cost-related business secrets. Business confidential

information has been indicated herein by enclosing it in single brackets (“[ ]”). A public version of these

comments is also being filed with all confidential information removed.

OMRON Management Center of America, Inc. submits this exclusion request on behalf of our business

unit. OMRON in the US is the only designer of this product and only supplier of this component.

CASE ASSY,MAS is plastic switch substrate and actuators, an OEM-specified dimension for power

window switches. It is only used for further assembly of components which go into domestic automobile

production, which is specified by auto manufacturer.

This product is not a target of the US Administration's 301 investigation regarding Intellectual Property

concerns. This is not a concern to IP transfer and impressment. This product contains no IP of interest

related to autonomous vehicle production.

The tariff action ultimately poses a risk of significant damage to OMRON, the domestic automobile

industry, and ultimately the US consumer as a increase in price. Like in the case of similar approvals for

vehicle components at the HTS level, OMRON views this product in the same manner. Immediate

movement of production to a US manufacturer or another country would pose significant re-tooling

costs, significant amounts of time, and approvals pertaining to consumer automobile safety standards are

costly and would take a significant amount of time to obtain.

OMRON Management Center of America, Inc. believes that CBP can easily exclude the CASE

ASSY,MAS in question based solely on the product description. The following are draft CBP exclusion

instructions:

"CASE ASSY,MAS flat rectangular assembly with four switches: two "u" shaped cross section actuators

in the middle of the switch, and two toggle switches oriented with the length of the assembly. Case

dimensions 137.1mm x 64mm x 37.2mm, Knob (DR A1): 27.34 mm x20.08mm x28.26mm Knob (A1):

27.34mm x20.08mm x28.26mm Knob (D/L L): 28.8mm x16mm x35.5mm Knob (W/L): 25.7mm x

20mm x 20.16mm."

This information will be contained on the invoice from the supplier.
#### STATE of Missouri, Respondent, v. Errol ISOM, Appellant. Errol ISOM, Appellant, v. STATE of Missouri, Respondent.

Nos. 64181, 65700.

Missouri Court of Appeals, Eastern District, Division Three.

March 7, 1995.

Deborah B. Wafer, St. Louis, for appellant.

Jeremiah W. (Jay) Nixon, Atty. Gen., Joanne E. Beal, Asst. Atty. Gen., Jefferson City, for respondent.

Before CRANE, P.J., and CRANDALL and DOWD, JJ.

ORDER

PER CURIAM.

Defendant appeals after a jury convicted him of possession of a controlled substance in violation of § 195.202, RSMo Supp.1993, and the motion court denied his Rule 29.15 motion on the merits without an evidentiary hearing. We affirm.

We find no error of law appears and the findings of fact issued by the motion court are not clearly erroneous. Rule 84.16(b)(2) and (5). Further, we find no jurisprudential purpose would be served by a written opinion in this case, and we affirm by written summary order. Rule 30.25(b). A memorandum setting forth the reasons for our decision has been issued to the parties for their use only.
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the
Annual Report of Destination Maternity Corporation (the Company) on Form 10-K/A for the period ending September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the Report), the
undersigned certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ Edward M. KrellEdward M. KrellChief Executive Officer & President(Principal Executive Officer)


May 26, 2011
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-07-00677-CR

Tracy Eugene Rickerson, Appellant

v.

The State of Texas, Appellee

FROM THE DISTRICT COURT OF WILLIAMSON COUNTY, 277TH JUDICIAL DISTRICT

NO. 07-478-K277, HONORABLE KEN ANDERSON, JUDGE PRESIDING

M E M O R A N D U M O P I N I O N

Tracy Eugene Rickerson seeks to appeal a judgment of conviction for driving

while intoxicated. The trial court has certified that: (1) this is a plea bargain case and Rickerson

has no right of appeal, and (2) Rickerson waived his right of appeal. The appeal is dismissed. See

Tex. R. App. P. 25.2(a)(2), (d).

___________________________________________

G. Alan Waldrop, Justice

Before Chief Justice Law, Justices Waldrop and Henson

Dismissed for Want of Jurisdiction

Filed: January 18, 2008

Do Not Publish
FedFirst Financial Corporation
10-Q








EXHIBIT
32.2








CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002








In
connection with the Quarterly Report of FedFirst Financial Corporation (the
“Company”) on Form 10-Q for the period ending March 31, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Robert
C. Barry Jr., the Chief Financial Officer and Executive Vice President of the
Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of
the Sarbanes-Oxley Act of 2002, that:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company








Date:
            May
      17, 2010
            
            /s/
      Robert C. Barry Jr.Robert
      C. Barry Jr.Chief
      Financial Officer and Executive Vice President
EXHIBIT 99.1


       REPORT OF ROBINSON, GRIMES & COMPANY, P.C., DATED JANUARY 31, 1999



[LETTERHEAD LOGO]
ROBINSON, GRIMES & COMPANY, P.C. 



REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

The Board of Directors
FLAG Financial Corporation
LaGrange, Georgia

We have audited the accompanying consolidated statements of operatIOns,  changes
in  stockholders'  equity and cash flows for the year ended December 31, 1996 of
FLAG Financial  Corporation and Subsidiary.  These financial  statements are the
responsibility of FLAG's management. Our responsibility is to express an opinion
on these financial statements based on our audit.

We conducted our audit in accordance with generally accepted auditing standards.
Those standards  require that we plan and perform the audit to obtain reasonable
assurance   about  whether  the   financial   statments  are  free  of  material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the consolidated  financial statements referred to above present
fairly,  in all material  respects,  the results of operations and cash flows of
FLAG Financial  Corporation and Subsidiary for the year ended December 31, 1996,
in conformity with generally accepted accounting principles.


/s/Robinson, Grimes & Company, P.C.

Certified Public Accountants

Columbus, Georgia
January 31, 1997
Exhibit
32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of China Health Industries Holdings, Inc. a
Delaware corporation (the “Company”), on Form 10-Q for the quarterly period
ending December 31, 2010 as filed with the Securities and Exchange Commission
(the “Report”), I, Xin Sun, Chief Executive Officer of the Company, certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section
1350), that to my knowledge:





(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.





/s/Xin
      SunXin
      SunChief
      Executive OfficerDate:  February
      14, 2011
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

March 15, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-6408

Apergy ESP Systems, LLC:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
**EXHIBIT 10.15**

January 9, 2003

Joseph A.Fusco [ADDRESS] 

| **Re:** | **Employment Agreement dated April 17, 2000 between Joseph A. Fusco and Trump Hotels & Casino Resorts, Inc., Trump Hotels & Casino Resorts Holdings, L.P. and TrumpAtlantic City Associates (collectively “Trump”) (the “Agreement”)** |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

Dear Mr. Fusco:

This letter willconfirm that the Agreement is hereby amended as set forth below:

| 1.     | the Expiration Date is extended to December 31, 2006;                                                                                      |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                       |
| 2.     | paragraph 2 is amended to reflect the annual base salary of $400,000; and                                                                  |
|   |                                                                                                                                       |
| 3.     | paragraph 3 is amended to state that commencing January 1, 2004 the annual salary shall be increased at a rate not less than 5% per annum. |

Except to the extent modified herein, you and Trump hereby ratify the Agreement and agree that all other terms, conditions and obligations contained therein remain in full force and effect as stated in theAgreement.

|   | Very truly yours,                         |   |
|--------|-------------------------------------------|--------|
|   |                                      |   |
|   | /s/ MARK A. BROWN                         |   |
|   |                                           |   |
|   | **MARK A. BROWN Chief Operating Officer** |   |

Agreed and Consented to:

| /s/ JOSEPH A. FUSCO |   |   |
|---------------------|--------|--------|
|                     |   |   |
| **Joseph A. Fusco** |   |   |
|                |   |   |
| 1/9/03              |   |   |
|                     |   |   |
| **Date**            |   |   |
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

AND CHIEF FINANCIAL OFFICER

PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

(18 U.S.C. 1350)

In connection with the Quarterly Report of The Money Tree Inc. (the Company) on Form 10-Q/A for the quarter ended March 25, 2008, as filed with the Securities and Exchange
Commission on the date hereof (the Report), the undersigned, Bradley D. Bellville, Chief Executive Officer of the Company, and Steven P. Morrison, Chief Financial Officer of the Company, hereby certify pursuant to Section 906 of The
Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), that, to the best of our knowledge and belief:



|(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|--- | ---------------------------------------------------------------------------------------------------------------------------------



|(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |     |  |                         
|----------------------- |  | --- |  | ------------------------
|Date: December 17, 2008 |  | By: |  | /s/ Bradley D. Bellville
|                        |  |     |  | Bradley D. Bellville    
|                        |  |     |  | Chief Executive Officer 
|                        |  |    
|Date: December 17, 2008 |  | By: |  | /s/ Steven P. Morrison  
|                        |  |     |  | Steven P. Morrison      
|                        |  |     |  | Chief Financial Officer
[Federal Register Volume 60, Number 73 (Monday, April 17, 1995)]
[Notices]
[Page 19307]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9393]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Importation of Controlled Substances; Notice of Application

    Pursuant to Section 1008 of the Controlled Substances Import and 
Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
regulation under Section 1002(a) authorizing the importation of such a 
substance, provide manufacturers holding registrations for the bulk 
manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with Section 1311.42 of Title 21, Code of 
Federal Regulations (CFR), notice is hereby given that on February 23, 
1995, Stepan Company, Natural Products Department, 100 W. Hunter 
Avenue, Maywood, New Jersey 07607, made application to the Drug 
Enforcement Administration to be registered as an importer of Coca 
Leaves (9040), a basic class of controlled substance in Schedule II.
    The firm plans to import the Coca Leaves to manufacture Cocaine 
under its DEA manufacturers registration.
    Any manufacturer holding, or applying for, registration as a bulk 
manufacturer of this basic class of controlled substance may file 
written comments on or objections to the application described above 
and may, at the same time, file a written request for a hearing on such 
application in accordance with 21 CFR 1301.54 in such form as 
prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, DC 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than (30 days from 
publication).
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1311.42 (b), (c), 
(d), (e), and (f). As noted in a previous notice at 40 FR 43745-46 
(September 23, 1975), all applicants for registration to import a basic 
class of any controlled substance in Schedule I or II are and will 
continue to be required to demonstrate to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration that the requirements for such registration pursuant to 
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42 (a), (b), (c), 
(d), (e), and (f) are satisfied.

    Dated: April 7, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-9393 Filed 4-14-95; 8:45 am]
BILLING CODE 4410-09-M
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

September 26, 2019

RE: Product Exclusion Request Number USTR-2018-0025-6665

Invacare Corp:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request did not contain a sufficient product identification or was 

determined to be non-administrable.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel